Tests of the CDK4/6i priming effect showed that the C‐P regimen had stronger anti‐tumor effects than C‐PC in both models, consistently resulting in the most extensive and durable tumor regression (Figure 2b,c,e,f). The gene discussed is CDK4; the disease is neoplasm.